Cure Alzheimer's Fund: Targeting Breakthrough Research

This project will further explore evidence that the Abeta peptide, acknowledged to be implicated in the cause of AD, may be an anti-microbial agent. More relevant articles: Glabe Paper Helps Confirm Prana Drug Strategy Amyloid beta protein may be a defense against Microbes! Drs. Rob Moir and... (Read more)

Investigating the increasingly documented link between TBI/stroke and Alzheimer’s disease is aimed at not only developing effective interruptions of that linkage but also a contribution to an understanding of the basic Alzheimer’s disease mechanism. Related articles: Alzheimer’s and Trauma... (Read more)

Cure Alzheimer's Fund is part of a funding consortium supporting collaborative biomarker investigation of the elevation of Tau and decreased concentrations of Amyloid beta 42 in the Central Spinal Fluid as evidence of the presence of the Alzheimer's disease pathology.   Leslie M ShawJohn Q. Troj... (Read more)